Cantor Fitzgerald Upgrades Galena Biopharma (GALE) to Hold
Tweet
Share
E-mail
Get Alerts GALE Hot Sheet
Price: $0.21 --0%
Rating Summary:
6 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Rating Summary:
6 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Join SI Premium – FREE
Cantor Fitzgerald upgraded Galena Biopharma (NASDAQ: GALE) from Sell to Hold with a price target of $2.00 (unchanged).
For an analyst ratings summary and ratings history on Galena Biopharma click here. For more ratings news on Galena Biopharma click here.
Shares of Galena Biopharma closed at $1.52 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley Upgrades Coloplast A/S (COLOB:DC) (CLPBY) to Equalweight
- SailPoint Technologies Holdings (SAIL) PT Raised to $25 by Cantor Fitzgerald on Solid Checks
- JPMorgan Upgrades Inari Amertron Bhd (INRI:MK) to Overweight
Create E-mail Alert Related Categories
UpgradesRelated Entities
Cantor FitzgeraldSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
